Consolidation therapy after autologous stem cell transplant in relapsed/refractory Hodgkin lymphoma.
Memorial Sloan Kettering Cancer Center, Weill Medical College of Cornell University, New York, New York.
Craig H
CH
Moskowitz
D000079963:Brentuximab Vedotin; D017326:Clinical Trials, Phase III as Topic; D060830:Consolidation Chemotherapy / Q000379:methods*; D018380:Hematopoietic Stem Cell Transplantation; D006689:Hodgkin Disease / Q000473:pathology / Q000628:therapy*; D006801:Humans; D018796:Immunoconjugates / Q000627:therapeutic use*; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy*; D016879:Salvage Therapy / Q000379:methods; D014182:Transplantation, Autologous
D018796:Immunoconjugates; D000079963:Brentuximab Vedotin